课题基金 / 基金详情

Understanding and manipulating Antibody Dependent Cell Cytotoxicity (ADCC) by human Natural Killer (NK) cells

Understanding and manipulating Antibody Dependent Cell Cytotoxicity (ADCC) by human Natural Killer (NK) cells
了解和操纵人类自然杀伤 (NK) 细胞的抗体依赖性细胞毒性 (ADCC)
批准号:
G0900850/1
负责人:
Daniel Davis
金额:
$43.15万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2010
资助国家:
英国
项目状态:
已结题
起止时间:
2010 至 --

项目摘要

项目成果

Daniel Davis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Biologists have given names to nearly all the different protein molecules that mediate communication between human cells. Now, the audacious goal of contemporary cell biology is to understand how the billion proteins in a live cell allow them to move, multiply, contribute to a brain or defend us against viruses and bacteria. Imaging where and when proteins interact with each other has a major role to play at this frontier. Recent imaging of just a few types of proteins has already led to important new concepts in how immune cells communicate with each other and how they recognize signs of disease. High-resolution microscope images of immune cells contacting other cells have revealed temporary membrane structures, often called immune synapses, similar to the synapses that nerve cells make with one another for communication. Proteins commonly segregate into specific regions at the contacts between cells, and exploring how such changing arrangements of proteins occur and how they control immune cell communication is the new science opened up by the immune synapse concept. Over the last decade the use of antibodies has revolutionised the treatment of severe human diseases, such as non hodgkins lymphoma (NHL) and rheumatoid arthritis (RA). One way that these antibodies work is by triggering Natural Killer cells to directly kill diseased target cells. Crucially, nobody has yet determined what happens at immune synapses when antibodies trigger killing of diseased cells. Here, we plan to use state-of-the-art technologies to image immune synapses during antibody-medaited killing with a view to learning how to best optimise antibodies for this function. We will apply the understanding gained from these basic studies to the rational design of modified antibodies for optimal efficiency in a range of disease treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Nanoscale Phenotype of Immune Responses in Health and Disease
  • 批准号:
    MR/W031698/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $231.21万
  • 财政年份:
    2023
  • 负责人:
    Daniel Davis
  • 依托单位:
Drug Delivery at the Immunological Synapse
  • 批准号:
    BB/I013407/2
  • 项目类别:
    Research Grant
  • 资助金额:
    $32.6万
  • 财政年份:
    2013
  • 负责人:
    Daniel Davis
  • 依托单位:
The supramolecular dynamics of human immune cell recognition and communication
  • 批准号:
    G1001044-E01/2
  • 项目类别:
    Research Grant
  • 资助金额:
    $131.62万
  • 财政年份:
    2013
  • 负责人:
    Daniel Davis
  • 依托单位:
Drug Delivery at the Immunological Synapse
  • 批准号:
    BB/I013407/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $46.27万
  • 财政年份:
    2012
  • 负责人:
    Daniel Davis
  • 依托单位:
海外基金